Following a discussion around summarization in Part 1, Part 2 discusses the method of pure abstraction in light of recent advances in deep learning and AI.
Integrated approaches can help enhance recruitment plans.
Evidence from a Phase III cancer trial points to notable advances in data-transfer tech.
The careful selection of sensor technology prioritized in clinical trials, considering regulatory compliance, data security, device characteristics, and the specific needs of the trials for successful and confident implementation.
In an interview with Applied Clinical Trials' sister publication, Pharmaceutical Executive, Elizabeth (Beth) Garner, chief scientific officer for Ferring Pharmaceuticals, discusses what it was like transitioning from working as a gynecologic oncologist and seeing patients to working in pharma, specifically clinical trials.
Study seeks to understand how different forms of data meet the needs of researchers.
Implementing disclosure and data transparency policies and procedures represents an opportunity for sponsors, rather than an obligation.
Improving the site-sponsor relationship can get trials off on the right foot and on a path for success.
The current lack of clinical trial professionals is a serious concern that's compromising the ability to conduct high-quality clinical trials, but it's not irreversible.
Trust-based relationships form the foundation for successful trial management.
Advances in technology open door for improved EHR to EDC transfer process.
Latest CISCRP study provides insight on proactive outreach.
Capacity management and stability offer value for clients, their employees and FSP vendors.
Poll taken by leading biotech executives in clinical development addresses state of data quality and management.
First-of-its-kind consortium dedicated to accelerating new medicines development through optimizing patient advocacy group—industry collaboration.
This article sets out a vision of adopting convenient alternative blood sampling approaches that places the needs of the patient at the center and enables active monitoring, before the onset of clinical events, leading to improved healthcare.
Thursday, September 30, 2021 at 11am EDT | 8am PDT | 4pm BST | 5pm CEST Give yourself a competitive edge by learning how the world’s leading designer of innovative clinical trials can help you integrate elements of economic theory to your clinical trial design. Optimize sample size, speed, and power by exploring a broader array of designs and quickly identifying those that meet your objectives.
Adjusting to the changing dynamics of the clinical research associate role.
Developing new pathways to overcome study-related challenges is key to realizing the promise of the latest gene therapies.
Why weighing all of the ‘DE&I’ components is critical at site and sponsor levels.
To derive the greatest benefits from eCOA technology, several elements must work together to create a strong foundation for sponsor success.
Pursuing new tools and capabilities in sample logistics, storage, and data analysis.
Pilot study seeks to validate new and more granular outsourcing model classifications in differentiating performance across custom contract-service approaches.
Key considerations in deploying fit-for-purpose digital health technologies in drug development.
Good scientific principles and practices are essential for maintaining quality data that patients can benefit from.
Increased outreach is necessary to combat poor recruitment and large focus on patients near study centers.
Understanding the role of social determinants on clinical trial participation and trust.
eTMF-blockchain technology offers a myriad of application benefits to data quality and integrity while ensuring compliance to ethical standards.
A look at the future of clinical trial laboratory testing amid the emerging use of new devices at the point of care.
How partnering with a CRO that has experience in both dermatology and innovative trial approaches can help sponsors differentiate their studies and facilitate recruitment.